Company attributes
B2X
CEO
Founder
AngelList URL
Legal Name
DefiniGEN Limited
Legal classification
Date Incorporated
April 7, 2011
Spun Out From
Number of Employees (Ranges)
11 – 50
Email Address
info@definigen.com0
enquiries@definigen.com
Phone Number
+161767432600
+4412234971130
Full Address
Moneta Building (B280) Babraham Research Campus Cambridge CB22 3AT UK0
Incorporation Reference
07595566
Investors
Founded Date
January 1, 2012
Total Funding Amount (USD)
10,475,437
Latest Funding Round Date
November 2020
Former CEO
Latest Funding Type
Wellfound ID
Country
Headquarters
Other attributes
Company Operating Status
Active
UKSIC Code
72110
DefiniGEN was founded in 2012 to industrialise the OptiDIFF stem cell production platform developed at the University of Cambridge, UK. The company specializes in the area of human induced pluripotent stem cell (iPSC) derived cell production and metabolic disease modelling.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
